[1] Canver CC. Conduit options in coronary artery bypass surgery. Chest. 1995;108(4):1150-1155.[2] Veith FJ,Moss CM,Sprayregen S,et al. Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity.Surgery. 1979;85(3):253-256.[3] Huang Y,Gloviczki P,Noel AA,et al. Early complications and long-term outcome after open surgical treatment of popliteal artery aneurysms: Is exclusion with saphenous vein bypass still the gold standard? J Vasc Surg. 2007;45(4):706-715.e1.[4] Klinkert P,Post PN,Breslau PJ,et al.Saphenous Vein Versus PTFE for Above-Knee Femoropopliteal Bypass. A Review of the Literature. Eur J Vasc Endovasc Surg. 2004;27:357-362.[5] Neale ML,Graham JC,Lane RJ,et al.The influence of graft type on patency of infrainguinal arterial bypass grafts. J Am Coll Surg.1994;178:155-163.[6] 杨红军,许海叶,王维慈,等.仿生结构小口径人造血管的制备与研究[C]. 第三届全国血管外科和组织工程学术会议暨第二届全国下肢血管疾病论坛论文集,2008.[7] Zheng W,Wang Z,Song L,et al.Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model. Biomaterials.2012;33(10):2880-2891.[8] 尹桂波.静电纺纳米纤维支架在组织工程中的应用进展[J].南通纺织职业技术学院学报:综合版,2007,7(2):15-18.[9] Hong Y,Ye SH,Nieponice A,et al. A small diameter, fibrous vascular conduit generated from a poly(ester urethane)urea and phospholipid polymer blend. Biomaterials.2009; 30: 2457-2467.[10] Qiu Y,Tarbell JM.Computational simulation of flow in the end-to-end anastomosis of a rigid graft and a compliant artery. ASAIO J. 1996;42(5):M702-709.[11] 向萍,李敏.静电纺丝制备小直径血管支架[J].材料导报A:综述篇, 2011,25(3):132-135.[12] Inoguchi H,Kwon IK,Inoue E,et al.Mechanical responses of a compliant electrospun poly(L-lactide-co-epsilon-caprolactone) small-diameter vascular graft. Biomaterials. 2006;27(8): 1470-1478.[13] Malin M,Hiljanen-Vainio M,Karjalainen T,et al.Biodegradable lactone copolymers. II. Hydrolytic study of ε-caprolactone and lactide copolymers. J ApplPolym Sci.1996;59(8):1289-1298.[14] Karjalainen T,Hiljanen-Vainio M,Malin M,et al.Biodegradable lactone copolymers. III. Mechanical properties of ε-caprolactone and lactide copolymers after hydrolysis in vitro. J Appl Polym Sci. 1996;59(8):1299-1304.[15] Hiljanen-Vainio M,Karjalainen T,Seppälä J.Biodegradable lactone copolymers. I. Characterization and mechanical behavior of ε-caprolactone and lactide copolymers. J Appl Polym Sci.1996;59(8):1281-1288.[16] Shin'oka T,Imai Y,Ikada Y.Transplantation of a tissue- engineered pulmonary artery. N Engl J Med. 2001;344:532-533.[17] Mo XM,Xu CY,Kotaki M,et al. Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials. 2004;25(10):1883-1890.[18] Mo XM,Weber HJ,Bhuju S,et al.Investigation of Biodegradable Nanofibers in Tubular Scaffolds for Tissue Regeneration. J Med Biomech.2005;20:90-91.[19] Zhang K,Yin A,Huang C,et al. Degradation of electrospun SF/P(LLA-CL) blended nanofibrous scaffolds in vitro.Polym Degrad Stabil. 2011;96:2266-2275.[20] Chen ZG,Wang PW,Wei B,et al. Electrospun collagen–chitosan nanofiber: A biomimetic extracellular matrix for endothelial cell and smooth muscle cell. Acta Biomaterialia. 2010;6:372-382.[21] Huang C,Geng X,Qinfei K,et al. Preparation of composite tubular grafts for vascular repair via electrospinning. Prog Nat Sci: Mater Int. 2012;22:108-114.[22] 钱永芳,莫秀梅,柯勤飞.明胶和壳聚糖共混静电纺[C].第六届中国国际纳米科技研讨会论文集,2007.[23] Huang C,Chen R,Ke Q,et al.Electrospun collagen-chitosan- TPU nanofibrous scaffolds for tissue engineered tubular grafts. Colloids Surf B Biointerfaces. 2011;82(2):307-315.[24] Su Y,Li X,Liu Y,et al. Encapsulation and Controlled Release of Heparin from Electrospun Poly(L-Lactide-co-epsilon- Caprolactone) Nanofibers. J Biomater Sci Polym Ed.2010 [Epub ahead of print].[25] Yan S,Li XQ,Tan LJ,et al.Poly(l-lactide-co-ε-caprolactone) electrospunnanofibers for encapsulating and sustained releasing proteins. Polymer.2009;50:4212-4219.[26] Chen F,Huang P,Mo XM. Electrospinning of Heparin Encapsulated P(LLA-CL) Core/Shell Nanofibers. Nano Biomed Eng.2010;2(1):84-90.[27] Su Y,Li X,Liu Y,et al. Encapsulation and Controlled Release of Heparin from Electrospun Poly(L-Lactide-co-epsilon- Caprolactone) Nanofibers. J Biomater Sci Polym Ed. 2010 [Epub ahead of print].[28] Chen R,Li XQ,Ke QF,et al. Fabrication and characterization of collagen (shell) /thermoplastic polyurethane (core) composite nanofibers by coaxial electrospinning. e-Polymers.2010; No009: 1618-7229.[29] Chen R,Huang C,Ke Q,et al. Preparation and characterization of coaxial electrospun thermoplastic polyurethane/collagen compound nanofibers for tissue engineering applications. Colloids Surf B Biointerfaces. 2010;79(2):315-325.[30] Stankus JJ,Soletti L,Fujimoto K,et al. Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization. Biomaterials. 2007; 28(17):2738-2746.[31] Yang X, Shah JD, Wang H. Nanofiber enabled layer-by-layer approach toward three-dimensional tissue formation. Tissue Eng Part A. 2009;15(4):945-956.[32] Du F,Wang H,Zhao W,et al.Gradient nanofibrous chitosan/poly varepsilon-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering. Biomaterials. 2012;33(3):762-770.[33] 刘隽炜,董念国.内皮祖细胞研究进展[J].心血管病学进展,2011, 32 (4):528-530.[34] Sayers RD,Raptis S,Berce M,et al. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br J Surg. 1998;85:934-938.[35] Faries PL,LoGerfo FW,Arora S, et al. A comparative study of alternative conduits for lower extremity revascularization: All-autogenous conduit versus prosthetic grafts. J Vasc Surg. 2000;32:1080-1090.[36] Cines DB,Pollak ES,Buck CA,et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood.1998; 91(10):3527-3561.[37] Jaffe EA. Physiologic Functions of Normal Endothelial Cells. Ann N Y Acad Sci. 1985;454:279-291.[38] 李桂琼, 陈庆伟.内皮祖细胞移植策略研究进展[J].心血管病学进展,2011,32 (3):411-414. [39] 赵清,魏盟.内皮祖细胞支架的研究进展[J].中华老年多器官疾病杂志,2008, 7(3):251-253. [40] Anderson SM,Chen TT,Iruela-Arispe ML,et al.The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF.Biomaterials. 2009;30:4618-4628.[41] Jun HW, West JL.Endothelialization of microporous YIGSR/PEG-modified polyurethaneurea. Tissue Eng.2005; 11(7-8): 1133-1140.[42] McCarthy JR,Weissleder R.Multifunctional magnetic nanoparticles for targeted imaging and therapy.Adv Drug Deliv Rev. 2008;60(11):1241-1251.[43] Suuronen EJ, Veinot JP, Wong S,et al. Tissue-engineered injectable colla¬gen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133 + progenitors expanded from the peripheral blood. Cir¬culation. 2006;114(1 suppl): I138-144.[44] Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind spe-cific ligands. Nature.1990;346( 6287): 818-822.[45] 熊党生.生物材料与组织工程[M].北京:科学出版社, 2010:163.[46] 石海涛,莫秀梅, 何创龙,等.肝素化纳米材料P(LLA-CL)的制备及其表征和抗凝血性特征[J]. 中国组织工程研究与临床康复, 2008,12(1):10-14. [47] Richardson TP,Peters MC,Ennett AB, et al. Polymeric system for dual growth factor delivery. Nat Biotechnol.2001; 19(11): 1029-1034. [48] Singh S,Wu BM,Dunn JC. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. Biomaterials. 2011;32(8): 2059-2069.[49] Nillesen STM,Geutjes PJ,Wismans R,et al.Increased angiogenesis and blood vessel maturation in acellular collagen–heparin scaffolds containing both FGF2 and VEGF. Biomaterials. 2007;28:1123-1131.[50] Jeon O,Song SJ,Kang SW,et al. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold. Biomaterials. 2007;28:2763-2771.[51] 赵长生.生物医用高分子材料[M].北京:化学工业出版社,2009: 33-42.[52] 曾伟杰,凌友,支晓兴.心血管支架材料生物力学及生物相容性特征[J].中国组织工程研究与临床康复,2008,12(13): 2531-2534.[53] Smith MJ,McClure MJ,Sell SA,et al.Suture-reinforced electrospunpolydioxanone–elastin small-diameter tubes for use in vascular tissue engineering: A feasibility study. Acta Biomaterialia. 2008;4:58-66.[54] Tillman BW,Yazdani SK,Lee SJ,et al.The in vivo stability of electrospunpolycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials. 2009;30:583-588.[55] He W, Ma Z,Teo WE,et al.Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts. J Biomed Mater Res A. 2009;90(1):205-216.[56] Nottelet B, Pektok E, Mandracchia D, et al. Factorial design optimization and in vivo feasibility of poly(ε-caprolactone)- micro- and nanofiber-based small diameter vascular grafts. J Biomed Mater Res A. 2009;89(4):865-875.[57] Pektok E,Nottelet B,Tille JC,et al.Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation. 2008;118(24):2563-2570. |